Aortic valvular calcification predicts restenosis after implantation of drug-eluting stents in patients on chronic haemodialysis

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1562-1567

  Ishii, Hideki ^a,b   Kumada, Yoshitake ^b   Toriyama, Takanobu ^b   Aoyama, Toru ^b   Takahashi, Hiroshi ^b   Amano, Tetsuya ^a   Yasuda, Yoshinari ^a   Yuzawa, Yukio ^a   Maruyama, Syoichi ^a   Matsuo, Seiichi ^a   Matsubara, Tatsuaki ^c   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagoya Kyoritsu Hospital   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Aortic valvular calcification; Coronary artery disease; Drug eluting stent; Haemodialysis; Percutaneous coronary intervention

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; AORTA VALVE DISEASE; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CALCIFICATION; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTENOSIS; STABLE ANGINA PECTORIS;

AGED; AORTIC VALVE; CALCINOSIS; CARDIOMYOPATHIES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK FACTORS;

EID: 65249108658     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn685     Document Type: Article

References (36)

1. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615
2. Cheung AK, Sarnak MJ, Yan G et al. The Hemodialysis (HEMO) Study. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362
3. Hemmelgarn BR, Ghali WA, Quan H et al. Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis 2001; 37: 64-71
4. Ting HH, Tahirkheil NK, Berger PB et al. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol 2001; 87: 630-633
5. Yasuda K, Kasuga H, Aoyama T et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 2006; 17: 2322-2332
6. Le Feuvre C, Dambrin G, Helft G et al. Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart 2001; 85: 556-560
7. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ et al. DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175-2183
8. Schampaert E, Cohen EA, Schlüter M et al. C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115
9. Ge L, Iakovou I, Cosgrave J et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 2005; 26: 1056-1062
10. Chieffo A, Morici N, Maisano F et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006; 113: 2542-2547
11. Nakazawa G, Tanabe K, Aoki J et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007; 69: 808-814
12. Aoyama T, Ishii H, Toriyama T et al. Sirolimus-eluting stents versus bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60
13. Wang AY, Ho SS, Wang M et al. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med 2005; 165: 327-332
14. Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003; 13: 159-168
15. Panuccio V, Tripepi R, Tripepi G et al. Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis 2004; 43: 479-484
16. Ryan TJ, Bauman WB, Kennedy JW et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutics Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993; 88: 2987-3007
17. Hase H, Nakamura M, Joki N et al. Independent predictors of resteno-sis after percutaneous coronary revascularization in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 2372-2377
18. Hase H, Joki N, Nakamura M et al. Favourable long-term outcome by repeated percutaneous coronary revascularization in diabetic haemodialysis patients. Nephrol Dial Transplant 2002; 17: 100-105
19. Lemos PA, Arampatzis CA, Hoye A et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005; 95: 167-172
20. Kuchulakanti PK, Torguson R, Chu WW et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2006; 97: 792-797
21. VirmaniR,FarbA,Burke AP. Coronary angioplasty from the perspective of atherosclerotic plaque: morphologic predictors of immediate success and restenosis. Am Heart J 1994; 127: 163-179
22. Fitgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty: an observational study using intravascular ultrasound. Circulation 1992; 86: 64-70
23. Rubel JR, Milford S. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population. Am J Kidney Dis 2003; 41: 411-421
24. Qunibi WY. Reducing the burden of cardiovascular calcification in patients with chronic kidney disease. J Am Soc Nephrol 2005; 16 (Suppl 2): S95-S102
25. Meeus F, Kourilsky O, Guerin AP et al. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int 2000; 76(Suppl): S140-S147
26. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 2006; 47: 1027-1034
27. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: patho-biological mechanisms and clinical implications. Circ Res 2006; 99: 1044-1059
28. Ketteler M, Gross ML, Ritz E. Calcification and cardiovascular problems in renal failure. Kidney Int 2005; 94(Suppl): S120-S127
29. Moe S, Drüeke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006: 69; 1945-1953
30. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003; 41: 1211-1217
31. Rajamannan NM, Subramaniam M, Caira FC et al. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 2005; 112(Suppl I): I229-I234
32. Moura LM, Ramos SF, Zamorano JL et al. Rosvastatin affecting aortic valve endothelium toslow the progression ofaortic stenosis. J Am Coll Cardiol 2007; 49: 554-561
33. Jensen LO, Thayssen P, Pedersen KE et al. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 2004; 110: 265-270
34. Okazaki S, Yokoyama T, Miyauchi K et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravas-cular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation 2004; 110: 1061-1068
35. Wanner C, Krane V, März W et al. German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
36. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-2211